Benjamin Boyerinas

2.1k total citations · 1 hit paper
16 papers, 1.7k citations indexed

About

Benjamin Boyerinas is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Benjamin Boyerinas has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Benjamin Boyerinas's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Benjamin Boyerinas is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Benjamin Boyerinas collaborates with scholars based in United States, Malaysia and Denmark. Benjamin Boyerinas's co-authors include Marcus E. Peter, Andrea E. Murmann, Sun-Mi Park, Annika Hau, Jeffrey Schlom, Caroline Jochéms, James L. Gulley, Kwong Y. Tsang, Massimo Fantini and Christopher R. Heery and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Cell.

In The Last Decade

Benjamin Boyerinas

16 papers receiving 1.7k citations

Hit Papers

The role of let-7 in cell differentiation and cancer 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The role of let-7 in cell differentiation and cancer
    2009 540 citations Benjamin Boyerinas, Sun-Mi Park et al. Endocrine Related Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Boyerinas United States 10 990 715 623 358 125 16 1.7k
Chunsheng Li United States 19 1.3k 1.3× 874 1.2× 617 1.0× 406 1.1× 101 0.8× 32 2.0k
Harvey W. Smith Canada 13 836 0.8× 450 0.6× 304 0.5× 215 0.6× 131 1.0× 18 1.4k
Charles H. Yoon United States 18 1.0k 1.0× 441 0.6× 750 1.2× 686 1.9× 85 0.7× 45 1.9k
Katsuhiko Nakashima Japan 18 1.0k 1.0× 430 0.6× 362 0.6× 571 1.6× 106 0.8× 24 1.9k
Barbara J. Schiemann United States 15 685 0.7× 368 0.5× 484 0.8× 807 2.3× 125 1.0× 17 1.8k
Samuel Godár Austria 10 781 0.8× 289 0.4× 491 0.8× 330 0.9× 64 0.5× 11 1.5k
Qi-Jing Li United States 11 777 0.8× 632 0.9× 451 0.7× 464 1.3× 196 1.6× 11 1.5k
Takeyuki Sugiura Japan 14 956 1.0× 388 0.5× 402 0.6× 205 0.6× 108 0.9× 25 1.4k
Ahmet Acar Türkiye 14 660 0.7× 388 0.5× 728 1.2× 221 0.6× 129 1.0× 34 1.4k
C. Pennington United Kingdom 3 510 0.5× 329 0.5× 438 0.7× 135 0.4× 78 0.6× 4 1.1k

Countries citing papers authored by Benjamin Boyerinas

Since Specialization
Citations

This map shows the geographic impact of Benjamin Boyerinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Boyerinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Boyerinas more than expected).

Fields of papers citing papers by Benjamin Boyerinas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Boyerinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Boyerinas. The network helps show where Benjamin Boyerinas may publish in the future.

Co-authorship network of co-authors of Benjamin Boyerinas

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Boyerinas. A scholar is included among the top collaborators of Benjamin Boyerinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Boyerinas. Benjamin Boyerinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lontos, Konstantinos, Yiyang Wang, Andrew Frisch, et al.. (2023). Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors. Journal for ImmunoTherapy of Cancer. 11(3). e006522–e006522. 59 indexed citations
2.
3.
4.
Morgan, Richard A. & Benjamin Boyerinas. (2016). Genetic Modification of T Cells. Biomedicines. 4(2). 9–9. 37 indexed citations
5.
Boyerinas, Benjamin, Caroline Jochéms, Massimo Fantini, et al.. (2015). Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells. Cancer Immunology Research. 3(10). 1148–1157. 360 indexed citations
6.
Tsang, Kwong-Yok, Benjamin Boyerinas, Caroline Jochéms, et al.. (2015). Antibody dependent cellular cytotoxicity activity of a novel anti-PD-L1 antibody, avelumab (MSB0010718C), on human tumor cells.. Journal of Clinical Oncology. 33(15_suppl). 3038–3038. 5 indexed citations
7.
Lepone, Lauren M., Renee N. Donahue, Benedetto Farsaci, et al.. (2015). Abstract 1316: Evaluation of immune cell subsets of cancer patients treated with a fully human IgG1 anti-PD-L1 MAb (MSB0010718C) capable of mediating ADCC of human tumor cells. Cancer Research. 75(15_Supplement). 1316–1316. 2 indexed citations
8.
Tucker, Jo A., Caroline Jochéms, Benjamin Boyerinas, et al.. (2014). Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis. Cancer Immunology Immunotherapy. 63(12). 1307–1317. 19 indexed citations
9.
Fallon, John T., Benjamin Boyerinas, Robert L. Schmitz, et al.. (2014). Anti-tumor effects of anti-PD-L1 therapy in an orthotopic bladder tumor model. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P101–P101. 3 indexed citations
10.
Boyerinas, Benjamin, et al.. (2013). Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. Blood. 121(24). 4821–4831. 179 indexed citations
11.
Jochéms, Caroline, Jo A. Tucker, Matteo Vergati, et al.. (2013). Identification and characterization of agonist epitopes of the MUC1-C oncoprotein. Journal for ImmunoTherapy of Cancer. 1(S1). 2 indexed citations
12.
Jochéms, Caroline, Jo A. Tucker, Matteo Vergati, et al.. (2013). Identification and characterization of agonist epitopes of the MUC1-C oncoprotein. Cancer Immunology Immunotherapy. 63(2). 161–174. 19 indexed citations
13.
Boyerinas, Benjamin, Sun‐Mi Park, Andrea E. Murmann, et al.. (2011). Let‐7 modulates acquired resistance of ovarian cancer to TaxanesviaIMP‐1‐mediated stabilization of multidrug resistance 1. International Journal of Cancer. 130(8). 1787–1797. 138 indexed citations
14.
Boyerinas, Benjamin, Sun-Mi Park, Annika Hau, Andrea E. Murmann, & Marcus E. Peter. (2009). The role of let-7 in cell differentiation and cancer. Endocrine Related Cancer. 17(1). F19–F36. 540 indexed citations breakdown →
15.
Boyerinas, Benjamin, Sun-Mi Park, Noam Shomron, et al.. (2008). Identification of Let-7–Regulated Oncofetal Genes. Cancer Research. 68(8). 2587–2591. 188 indexed citations
16.
Feig, Christine, Benjamin Boyerinas, Jörg Volkland, et al.. (2005). Phosphorylation of FADD at Serine 194 by CKIα Regulates Its Nonapoptotic Activities. Molecular Cell. 19(3). 321–332. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunsheng Li Breakdown of academic impact, for papers by Harvey W. Smith Breakdown of academic impact, for papers by Charles H. Yoon Breakdown of academic impact, for papers by Katsuhiko Nakashima Breakdown of academic impact, for papers by Barbara J. Schiemann Breakdown of academic impact, for papers by Samuel Godár Breakdown of academic impact, for papers by Qi-Jing Li Breakdown of academic impact, for papers by Takeyuki Sugiura Breakdown of academic impact, for papers by Ahmet Acar Breakdown of academic impact, for papers by C. Pennington
Rankless by CCL
2026